vs

Side-by-side financial comparison of Arcosa, Inc. (ACA) and VEON Ltd. (VEON). Click either name above to swap in a different company.

VEON Ltd. is the larger business by last-quarter revenue ($1.1B vs $716.7M, roughly 1.5× Arcosa, Inc.). VEON Ltd. runs the higher net margin — 55.9% vs 7.3%, a 48.7% gap on every dollar of revenue. On growth, Arcosa, Inc. posted the faster year-over-year revenue change (7.6% vs 5.8%).

Arcosa, Inc. is a provider of infrastructure-related products and solutions operating across three core segments: construction, energy, and transportation. It offers products including utility structures, construction aggregates, and transportation components, primarily serving customers across the North American market to support critical infrastructure development projects.

VEON Ltd., also known as VEON Group, is a multinational telecommunication and digital services company. Headquartered in Dubai, the company is publicly traded on the U.S.-based NASDAQ stock exchange. VEON operates in six markets in Europe and Asia, including Bangladesh, Kazakhstan, Kyrgyzstan, Pakistan, Ukraine and Uzbekistan. Specific brands include Banglalink in Bangladesh, Jazz in Pakistan, Kyivstar in Ukraine, and units operating in Kazakhstan, Kyrgyzstan, and Uzbekistan under the Beeline...

ACA vs VEON — Head-to-Head

Bigger by revenue
VEON
VEON
1.5× larger
VEON
$1.1B
$716.7M
ACA
Growing faster (revenue YoY)
ACA
ACA
+1.7% gap
ACA
7.6%
5.8%
VEON
Higher net margin
VEON
VEON
48.7% more per $
VEON
55.9%
7.3%
ACA

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ACA
ACA
VEON
VEON
Revenue
$716.7M
$1.1B
Net Profit
$52.1M
$608.0M
Gross Margin
22.9%
Operating Margin
11.0%
75.4%
Net Margin
7.3%
55.9%
Revenue YoY
7.6%
5.8%
Net Profit YoY
776.6%
583.1%
EPS (diluted)
$1.06
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACA
ACA
VEON
VEON
Q4 25
$716.7M
Q3 25
$797.8M
Q2 25
$736.9M
$1.1B
Q1 25
$632.0M
Q4 24
$666.2M
Q3 24
$640.4M
Q2 24
$664.7M
$1.0B
Q1 24
$598.6M
Net Profit
ACA
ACA
VEON
VEON
Q4 25
$52.1M
Q3 25
$73.0M
Q2 25
$59.7M
$608.0M
Q1 25
$23.6M
Q4 24
$-7.7M
Q3 24
$16.6M
Q2 24
$45.6M
$89.0M
Q1 24
$39.2M
Gross Margin
ACA
ACA
VEON
VEON
Q4 25
22.9%
Q3 25
24.1%
Q2 25
22.5%
Q1 25
19.8%
Q4 24
19.3%
Q3 24
21.3%
Q2 24
20.8%
Q1 24
18.6%
Operating Margin
ACA
ACA
VEON
VEON
Q4 25
11.0%
Q3 25
14.1%
Q2 25
12.9%
75.4%
Q1 25
8.8%
Q4 24
6.5%
Q3 24
5.3%
Q2 24
10.1%
27.1%
Q1 24
8.9%
Net Margin
ACA
ACA
VEON
VEON
Q4 25
7.3%
Q3 25
9.2%
Q2 25
8.1%
55.9%
Q1 25
3.7%
Q4 24
-1.2%
Q3 24
2.6%
Q2 24
6.9%
8.7%
Q1 24
6.5%
EPS (diluted)
ACA
ACA
VEON
VEON
Q4 25
$1.06
Q3 25
$1.48
Q2 25
$1.22
$0.34
Q1 25
$0.48
Q4 24
$-0.16
Q3 24
$0.34
Q2 24
$0.93
$0.04
Q1 24
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACA
ACA
VEON
VEON
Cash + ST InvestmentsLiquidity on hand
$214.6M
$1.3B
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$2.6B
$1.5B
Total Assets
$5.0B
$8.5B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACA
ACA
VEON
VEON
Q4 25
$214.6M
Q3 25
$220.0M
Q2 25
$189.7M
$1.3B
Q1 25
$167.9M
Q4 24
$187.3M
Q3 24
$756.8M
Q2 24
$103.7M
$862.0M
Q1 24
$176.5M
Total Debt
ACA
ACA
VEON
VEON
Q4 25
$1.5B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.2B
Q2 24
$699.9M
Q1 24
$600.6M
Stockholders' Equity
ACA
ACA
VEON
VEON
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$2.5B
$1.5B
Q1 25
$2.5B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
$1.1B
Q1 24
$2.4B
Total Assets
ACA
ACA
VEON
VEON
Q4 25
$5.0B
Q3 25
$5.1B
Q2 25
$5.0B
$8.5B
Q1 25
$4.9B
Q4 24
$4.9B
Q3 24
$4.4B
Q2 24
$3.8B
$7.3B
Q1 24
$3.7B
Debt / Equity
ACA
ACA
VEON
VEON
Q4 25
0.57×
Q3 25
0.61×
Q2 25
0.67×
Q1 25
0.68×
Q4 24
0.69×
Q3 24
0.51×
Q2 24
0.29×
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACA
ACA
VEON
VEON
Operating Cash FlowLast quarter
$120.0M
Free Cash FlowOCF − Capex
$55.8M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
9.0%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$175.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACA
ACA
VEON
VEON
Q4 25
$120.0M
Q3 25
$160.6M
Q2 25
$61.2M
Q1 25
$-700.0K
Q4 24
$248.2M
Q3 24
$135.0M
Q2 24
$38.3M
Q1 24
$80.5M
Free Cash Flow
ACA
ACA
VEON
VEON
Q4 25
$55.8M
Q3 25
$121.0M
Q2 25
$33.4M
Q1 25
$-34.7M
Q4 24
$194.9M
Q3 24
$100.6M
Q2 24
$-9.3M
Q1 24
$26.1M
FCF Margin
ACA
ACA
VEON
VEON
Q4 25
7.8%
Q3 25
15.2%
Q2 25
4.5%
Q1 25
-5.5%
Q4 24
29.3%
Q3 24
15.7%
Q2 24
-1.4%
Q1 24
4.4%
Capex Intensity
ACA
ACA
VEON
VEON
Q4 25
9.0%
Q3 25
5.0%
Q2 25
3.8%
Q1 25
5.4%
Q4 24
8.0%
Q3 24
5.4%
Q2 24
7.2%
Q1 24
9.1%
Cash Conversion
ACA
ACA
VEON
VEON
Q4 25
2.30×
Q3 25
2.20×
Q2 25
1.03×
Q1 25
-0.03×
Q4 24
Q3 24
8.13×
Q2 24
0.84×
Q1 24
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACA
ACA

Engineered Structures$301.1M42%
Total Construction Materials$276.8M39%
Specialty Materials And Asphalt$110.2M15%
Construction Site Support$28.6M4%

VEON
VEON

Segment breakdown not available.

Related Comparisons